Better diabetes control with Dexcom G7 CGM System

Written in collaboration with Dexcom

For people with diabetes, controlling glucose levels is a constant challenge. Daily concerns about the disease, having to guess how much insulin to administer, and factors such as diet, activity, and stress can all impact glucose levels.

Fortunately, thanks to the innovation of Dexcom technologies, the all-new Dexcom G7 Continuous Glucose Monitoring (CGM) system can offer an improved and superior experience for people with diabetes.

Dexcom G7 CGM system technology

The Dexcom G7 CGM System enables glucose values to be transmitted to your smart device† continuously, without the need for routine finger pricking*. Information, such as glucose levels and how they change, is accessible 24 hours a day, allowing you to make the best possible dietary and physical activity decisions at the right times.

How the Dexcom G7 CGM System works

This unique and innovative system uses a sensor to broadcast your glucose values in real time to your display device.

The Dexcom G7 CGM System includes the following components:

1. A sensor with a small wire inserted under your skin
2. An all-in-one sensor applicator
3. A display device, either a compatible smart device† or the Dexcom G7 receiver, to view your result

The sensor takes constant, real-time readings of your glucose levels.

Measuring glucose levels with the Dexcom G7 CGM System

The Dexcom G7CGM System measures glucose levels through interstitial fluid with unmatched accuracy ^‡,1. It enables you to track glucose levels over time. Since you have access to your glucose results at any time you want via your smart device^†, you can react quickly if your results are less than optimal. Thanks to the system, you can refocus on achieving your target glucose range, regardless of your day-to-day activities.

The advantages of the Dexcom G7 CGM System for diabetes control

The new Dexcom G7 CGM System offers many advantages, including:

• The most accurate CGM System ^‡,1
• Demonstrated reduction in HBa1c levels^2-6
• A warning is issued before glucose levels become too low
• Data transmitted in real time
• Coverage from most private insurers and provincial health insurance programs^§,1

Enhancements to the new Dexcom G7 CGM System

Switching from the Dexcom G6 System to the Dexcom G7 System has many advantages for users, given the improvements made to the new device. For example^7,8, take advantage of:

• An even smaller sensor (60% smaller than the G6)
• All-in-one sensor and transmitter (separate sensor and transmitter for the G6)
• Automatic start-up in less than 30 minutes (2-hour start-up for the G6)
• Can be used during pregnancy (not applicable to G6)
• Application redesigned to include Dexcom Clarity data
• Time before 1st alert (high glucose alert) (not applicable to G6)
• Waterproof, 2.4 meters - Up to 24 hours (the G6 is waterproof)
• And much, much more!

The G6 and G7 sensors can be worn for up to 10 days. What's more, the Dexcom G7 sensor has a grace period of 12 hours, giving you time to change sensors at a time that's right for you.

Certain conditions apply.

Consult our free guide, Living with diabetes, to learn more about the condition.

* If the alerts and glucose results obtained with the Dexcom G7 CGM System do not correspond to symptoms or expectations, use a blood glucose meter for any diabetes-related therapeutic decision.

For more information on the Dexcom G7 CMS system, please visit https://www.dexcom.com/en-ca.

†Smart devices sold separately. For a list of compatible devices, visit dexcom.com/compatibility.

‡ Compared to other CGM Systems sold in Canada in August 2024.

§ Eligibility and coverage vary by policy, plan and payer. For more information, prescribers can go to ca.provider.dexcom.com/en/coverage, while patients can call Dexcom Canada toll-free at 1 844 832-1810 with any questions.  

1. Dexcom, internal data, 2024. 

2. Beck RW, et al. JAMA. 2017;317(4):371-378. 

3. Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 

4. Martens T, et al. JAMA. 2021;325(22):2262-2272. 

5. Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 

6. Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 

7. Dexcom G7 User's Guide, 2023.

8. Dexcom G6 User's Guide, 2021.

Dexcom, Dexcom G6, Dexcom G7, and Dexcom Follow are registered trademarks of Dexcom Inc. in the United States and may be registered in other countries. 2024, Dexcom Canada, Co. All rights reserved. MAT-4563 V1.0